IL17A and asthma: AYC-EV (8 mg/kg)-treated asthma-induced mice (G4) showed decreased levels of IFN-γ+CD4+, IL-5+CD4+, IL-17A+CD4+, and IL-5+IL-17A+CD4+ T cells as compared to the disease-causing groups (G2) (Figure 8a).